Research Articles

Neurological diseases
Impeto Medical

SUDOSCAN combined to other diagnosis tests to confirm small fiber neuropathy

SUDOSCAN COMBINED TO OTHER DIAGNOSIS TESTS TO CONFIRM SMALL FIBER NEUROPATHY   V. Fabry, A. Gerdelat, B. Acket, P. Cintas, V. Rousseau, E. Uro-Coste, S. M. Evrard and A. Pavy-Le Traon. Article title: “Which Method for Diagnosing Small Fiber Neuropathy?” Front. Neurol., 05 May 2020. In a recent study conducted at Toulouse University Hospital, France,

Read More »
Diabetes
Impeto Medical

The utility of SUDOSCAN to diagnose diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy

THE UTILITY OF SUDOSCAN TO DIAGNOSE DIABETIC CARDIOVASCULAR AUTONOMIC NEUROPATHY AND DIABETIC POLYNEUROPATHY C. D’amato, C. Greco, G. Lombardo, V. Frattina, M. Campo, C.M.A. Cefalo, V. Izzo, D. Lauro, V. Spallone. Article title: “The diagnostic usefulness of the combined COMPASS 31 questionnaire and electrochemical skin conductance for diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy” J

Read More »
Diabetes
Impeto Medical

The benefits of SUDOSCAN in early diagnosis of diabetic peripheral neuropathy reviewed in The Lancet

THE BENEFITS OF SUDOSCAN IN EARLY DIAGNOSIS OF DIABETIC PERIPHERAL NEUROPATHY REVIEWED IN THE LANCET Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. Article title: “Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention”. The Lancet Diabetes Endocrinol 2019. Volume 7, Issue 12, p938-948, December

Read More »
Follow-up with SUDOSCAN
Impeto Medical

Longitudinal follow-up with SUDOSCAN

LONGITUDINAL FOLLOW-UP: SUDOSCAN DEMONSTRATED EFFICACY IN RESULTS FOLLOW-UP SUDOSCAN has proven its clinical utility in the follow-up of sudomotor function. In a Finnish study, SUDOSCAN was used to evaluate the effect of physical activity on cardiovascular risk and metabolic diseases.  In patients with the highest level of weekly physical activity (as measured with a pedometer),

Read More »
Oncology
Impeto Medical

SUDOSCAN in Oncology : Chemotherapy Induced Polyneuropathy

SUDOSCAN in Oncology : Chemotherapy InduCed Polyneuropathy Two studies evaluating SUDOSCAN Severe drug-induced neurotoxic adverse effects constitute the second most common cause of dose limitation after haematological adverse effects.  Chemotherapy Induced Polyneuropathy (CIPN) is commonly associated with platinum analogues, antitubulins (taxane), the proteasome inhibitor bortezomib, and thalidomide. However, it is poorly investigated at an early

Read More »
News
Impeto Medical

Worldwide Business with kathy ireland® Interviews Impeto Medical to Discuss Their Promising Breakthrough Product for Diabetes Patients and Physicians

Los Angeles, CA – February 14, 2017 — Impeto Medical CEO and Founder Philippe Brunswick is featured on the award-winning, global TV show, Worldwide Business with kathy ireland®. The segment’s topic is the introduction of the company’s innovative, non-invasive SUDOSCAN™ medical device. Impeto Medical is a privately-owned medical device company. The company’s mission is to

Read More »
Scroll to Top